David Gremmelspacher M.Sc.
David is a Ph.D. student in the Aceto lab. He studied pharmacy at the University of Freiburg, Germany and received his pharmaceutical license in 2021. During his studies he joined the Department of Clinical and Experimental Pharmacology and Toxicology in Freiburg for a research course under supervision of Prof. Gilsbach, establishing Nanopore Sequencing for direct RNA sequencing of cardiac RNAs. After his university studies he joined the Quality Department at Pfizer Manufacturing Germany and a local pharmacy to extend his knowledge in drug sciences.